Preliminary Epidemiological and Clinical Profile of the 2024 Pediatric Pertussis Outbreak: A Retrospective Analysis
-
By
-
Lin, Xiang
-
Qiu, Yuhong
-
Huang, Zhifang
-
Lin, Quan
-
Sheng, Yingjie
-
Zeng, Qingchun
-
Tang, Heng
-
June 29, 2026
-
Clinical Scorecard: Epidemiological and Clinical Characteristics of the Pediatric Pertussis Outbreak in 2024: A Retrospective Study
At a Glance
| Category | Detail |
|---|
| Condition | Pediatric Pertussis |
| Key Mechanisms | Atypical symptoms, increased hospitalization rates, prolonged hospitalization linked to afebrile presentations. |
| Target Population | Infants and preschool-aged children, with notable incidence in school-aged children. |
| Care Setting | Hospitalized pediatric cases |
Key Highlights
- 2024 outbreak characterized by atypical symptoms and increased hospitalization rates.
- Prolonged hospitalization correlated with absence of fever and normal inflammatory markers.
- Elevated platelet counts and increased ALT levels identified as predictors of extended hospital stays.
- Outbreak peaked in June-July and declined by August.
- Study based on 69 PCR-confirmed pediatric pertussis cases.
Guideline-Based Recommendations
Diagnosis
- PCR confirmation of pertussis cases.
Management
- Monitor for atypical symptoms and hospitalization duration.
Monitoring & Follow-up
- Evaluate platelet counts and ALT levels for risk assessment.
Risks
- Prolonged hospitalization in afebrile patients with normal inflammatory markers.
Patient & Prescribing Data
Pediatric patients hospitalized during the 2024 pertussis outbreak.
Clinical risk stratification may benefit from monitoring specific laboratory markers.
Clinical Best Practices
- Consider atypical presentations in pediatric pertussis cases.
- Utilize laboratory markers for predicting hospitalization duration.
Related Resources & Content
